Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Roden

Showing results (61-70 of 1,010) with videos related to

Pageof 101
Sort By:
The American Journal of Cardiology|October 19, 1988
Role of the electrocardiogram in determining electrophysiologic end points of drug therapyD M Roden
Cardiovascular Research|May 4, 2001
Pharmacogenetics and drug-induced arrhythmiasD M Roden
Journal of the American College of Cardiology|July 11, 2002
The problem, challenge and opportunity of genetic heterogeneity in monogenic diseases predisposing to sudden deathDan M Roden
Clinical Cardiology|September 1, 1993
Torsade de pointesD M Roden
Trends in Cardiovascular Medicine|June 12, 2017
Reprint of Editiorial Commentary: Genomics and drug discovery: The next frontier in precision medicineDan M Roden
Heart Rhythm|February 5, 2010
Brugada syndrome: lots of questions, some answersDan M Roden
Circulation|September 4, 2008
Repolarization reserve: a moving targetDan M Roden
Postgraduate Medicine|September 15, 1985
Antiarrhythmic drugs. Clinical pharmacology of the old and the new agentsD M Roden
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|April 9, 2011
Personalized medicine and the genotype-phenotype dilemmaDan M Roden
Archives Des Maladies Du Coeur Et Des Vaisseaux|February 1, 1996
Is there a need for new antiarrhythmic drugs?D M Roden
Pageof 101

Showing results (61-70 of 1,010) with videos related to

Sort By:
Pageof 101
The American Journal of Cardiology|October 19, 1988
Role of the electrocardiogram in determining electrophysiologic end points of drug therapyD M Roden
Cardiovascular Research|May 4, 2001
Pharmacogenetics and drug-induced arrhythmiasD M Roden
Journal of the American College of Cardiology|July 11, 2002
The problem, challenge and opportunity of genetic heterogeneity in monogenic diseases predisposing to sudden deathDan M Roden
Clinical Cardiology|September 1, 1993
Torsade de pointesD M Roden
Trends in Cardiovascular Medicine|June 12, 2017
Reprint of Editiorial Commentary: Genomics and drug discovery: The next frontier in precision medicineDan M Roden
Heart Rhythm|February 5, 2010
Brugada syndrome: lots of questions, some answersDan M Roden
Circulation|September 4, 2008
Repolarization reserve: a moving targetDan M Roden
Postgraduate Medicine|September 15, 1985
Antiarrhythmic drugs. Clinical pharmacology of the old and the new agentsD M Roden
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|April 9, 2011
Personalized medicine and the genotype-phenotype dilemmaDan M Roden
Archives Des Maladies Du Coeur Et Des Vaisseaux|February 1, 1996
Is there a need for new antiarrhythmic drugs?D M Roden
Pageof 101